Donald R. Joseph J.D.
Net Worth
Last updated:
What is Donald R. Joseph J.D. net worth?
The estimated net worth of Mr. Donald R. Joseph J.D. is at least $2,451,400 as of 24 Jul 2020. He has received compensation worth at least $2,451,400 in Acer Therapeutics Inc..
What is the salary of Donald R. Joseph J.D.?
Mr. Donald R. Joseph J.D. salary is $490,280 per year as Chief Legal Officer & Sec. in Acer Therapeutics Inc..
How old is Donald R. Joseph J.D.?
Mr. Donald R. Joseph J.D. is 71 years old, born in 1954.
What stocks does Donald R. Joseph J.D. currently own?
As insider, Mr. Donald R. Joseph J.D. owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Acer Therapeutics Inc. (ACER) | Chief Legal Officer & Sec. | 14,285 | $0 | $0 |
What does Acer Therapeutics Inc. do?
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-001, a formulation of sodium phenylbutyrate for the treatment of various inborn errors of metabolism, including urea cycle disorders and maple syrup urine disease; ACER-801 (osanetant) for the treatment of induced Vasomotor Symptoms; and ACER-2820 (emetine), a host-directed therapy against a variety of infectious diseases, including COVID-19. The company has a research collaboration agreement with the National Center for Advancing Translational Sciences (NCATS) to develop emetine hydrochloride as a potential treatment for patients with COVID-19; and a license agreement with Sanofi to acquire worldwide rights to osanetant, a clinical-stage, selective, and non-peptide tachykinin NK3 receptor antagonist. Acer Therapeutics Inc. was incorporated in 1991 and is headquartered in Newton, Massachusetts.
Donald R. Joseph J.D. insider trading
Acer Therapeutics key executives
Acer Therapeutics Inc. executives and other stock owners filed with the SEC:
- Mr. Christopher Schelling (49) Founder, Pres, Chief Executive Officer & Director
- Mr. Donald R. Joseph J.D. (71) Chief Legal Officer & Sec.
- Mr. Harry S. Palmin (55) Chief Operating Officer & Chief Financial Officer